Sam Keeping

Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma

Olalekan O. Oluwole, Jeroen P. Jansen, Vincent Lin et al. · Biology of Blood and Marrow Transplantation · 2020 · 56 citations

<scp>Real‐world</scp> experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The <scp>SCHOLAR</scp>‐2 retrospective chart review study

Martin Dreyling, Lucie Obéric, Eva Giné et al. · British Journal of Haematology · 2022 · 37 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Oncology +12

The cost of oropharyngeal cancer in England: A retrospective hospital data analysis

Sam Keeping, M.J. Tempest, Sue Stephens et al. · Clinical Otolaryngology · 2017 · 30 citations · Full text

Cost-Effectiveness of Cemiplimab Versus Standard of Care in the United States for First-Line Treatment of Advanced Non-small Cell Lung Cancer With Programmed Death-Ligand 1 Expression ≥50%

Andreas Kuznik, Caitlin Smare, Chieh-I Chen et al. · Value in Health · 2021 · 29 citations

Matching-adjusted indirect comparison of axi-cel and liso-cel in relapsed or refractory large B-cell lymphoma

Olalekan O. Oluwole, Jenny M. H. Chen, Keith Syson Chan et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2022 · 15 citations